Healthcare & Life Sciences

Neovasc

activeseries-c-plus
series-c-plus
Stage
2
Investors

About

Neovasc is a specialty vascular device company that develops medical devices including the Reducer for treating refractory angina and the Tiara system for percutaneous mitral valve replacement.

Explore Neovasc's full profile on Brouky

Funding rounds, investor list, and risk signals — unlock with a subscription.